Sun et al. [72] showed that Juglanin treatment alleviates bleomycin-triggered lung fibrosis by inhibiting the STING signaling pathway in mice, which indicate that STING is involved in the pathogenesis of bleomycin-induced IPF. The gene discussed is STING1; the disease is idiopathic pulmonary fibrosis.